Biology Reference
In-Depth Information
De Donato, M., Mariani, M., Petrella, L., Martinelli, E., Zannoni, G. F., Vellone, V., et al.
(2011). Class III b -tubulin and the cytoskeletal gateway for drug resistance in ovarian can-
cer. Journal of Cellular Physiology , 227 , 1034-1041.
Esquela-Kerscher, A., & Slack, F. J. (2006). Oncomirs-microRNAs with a role in cancer.
Nature Reviews. Cancer , 6 , 259-269.
Gregory, R. I., Chendrimada, T. P., Cooch, N., & Shiekhattar, R. (2005). Human RISC couples
microRNA biogenesis and posttranscriptional gene silencing. Cell , 123 , 631-640.
Heneghan, H. M., Miller, N., & Kerin, M. J. (2010). MiRNAs as biomarkers and therapeutic
targets in cancer. Current Opinion in Pharmacology , 10 , 543-550.
Jedamzik, B., & Eckmann, C. R. (2009). Analysis of RNA-protein complexes by RNA coim-
munoprecipitation and RT-PCR analysis from Caenorhabditis elegans. Cold Spring
Harb Protoc. 2009 (10):pdb.prot5300. http://dx.doi.org/10.1101/pdb.prot5300 .
Kamath, K., Wilson, L., Cabral, F., & Jordan, M. A. (2005). b III-Tubulin induces paclitaxel
resistance in association with reduced effects on microtubule dynamic instability. The
Journal of Biological Chemistry , 280 (13), 12902-12907.
Liang, Y., Ridzon, D., Wong, L., & Chen, C. (2007). Characterization of microRNA expres-
sion profiles in normal human tissues. BMC Genomics , 8 , 166. http://dx.doi.org/10.1186/
1471-2164-8-166 .
Lobert, S., Mary E. Graichen, and Morris, K. (2013). Coordinated regulation of b -tubulin
isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells.
In press Biochemistry .
Lobert, S., Hiser, L., & Correia, J. J. (2010). Expression profiling of tubulin isotypes and mi-
crotubule interacting proteins using real-time polymerase chain reaction. In J. J. Correia, &
L. Wilson (Eds.), Methods in cell biology, microtubules, in vitro. Chennai, India: Elsevier.
Lobert, S., Jefferson, B., &Morris, K. (2011). Regulation of b -tubulin isotypes by micro-RNA
100 in MCF7 breast cancer cells. Cytoskeleton , 68 , 355-362.
Nagaraja, A. K., Creighton, D. J., Yu, S., Zhu, H., Gunaratne, P. H., Reia, J. G., et al. (2010). A
link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Molecular Endocri-
nology , 24 (2), 447-463.
Pachter, J. S., Yen, T. J., & Cleveland, D. W. (1987). Autoregulation of tubulin expression is
achieved through specific degradation of polysomal tubulin mRNAs. Cell , 51 , 283-292.
Redshaw, R., Wilkes, T., Whale, A., Cowen, S., Huggett, J., & Foy, C. A. (2013). A compar-
ison of miRNA isolation and RT-qPCR technologies and their effects on quantification
accuracy and repeatability. BioTechniques , 54 (3), 155-164.
Theodorakis, N. G., & Cleveland, D. W. (1992). Physical evidence for cotranslational regu-
lation of b -tubulin mRNA degradation. Molecular and Cellular Biology , 12 (2), 791-799.
Yen, T. J., Gay, D. A., Pachter, J. S., & Cleveland, D. W. (1988). Autoregulated changes in
stability of polyribosome-bound b -tubulin mRNAs are specified by the first 13 translated
nucleotides. Molecular and Cellular Biology , 8 (3), 1224-1235.
Yu, Z., Baserga, R., Chen, L., Wang, C., Lisanti, M. P., & Pestell, R. G. (2010). MicroRNA,
cell cycle and human breast cancer. The American Journal of Pathology , 176 (3),
1058-1064.
Zhang, J., Chiodini, R., Badr, A., & Zhang, G. (2011). The impact of next-generation sequenc-
ing on genomics. Journal of Genetics and Genomics , 38 (3), 95-109.
Search WWH ::




Custom Search